The Science of Neuropsychiatric Medications and The Application in Pediatric Practice
1.75 NAPNAP contact hour, of which 1.75 is Pharmacology and 1.75 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $17.5 for NAPNAP Members. For non- members, this continuing education activity rate is $35.
This presentation reviews the neurological/biological basis and treatment of psychiatric conditions common to children and adolescents. The presenters will cover the basic anatomy and physiology of the brain to guide a neurological review of common pediatric psychiatric conditions. This knowledge is then used to discuss the pharmacological treatment of psychiatric conditions in the clinical setting.
Introduction: This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.75 NAPNAP contact hour, of which 1.75 is Pharmacology and 1.75 Psychopharmacology.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
Copyright 2021 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Pediatric-focused advanced practice registered nurses
- Describe the neurological basis of psychiatric illness in children and its treatment
- Discuss the neurological basis of medications for psychiatric illness
- Describe indications for the use of specific medications with children and adolescents
Joshua Palmer, DNP, PMHNP, RN and Susan Van Cleve, DNP, RN, CPNP-PC, PMHS, FAANP
Dr. Palmer has presented and published on psychiatric topics across the lifespan including screening for adolescent vaping use, adolescent substance use, opioid use disorder treatments, neurobiological perspectives of mental illness and methods to reduce medication use for behavioral disturbances in dementia. Today, he continues to evaluate the impact of the COVID-19 pandemic on the treatment delivery of psychiatric treatment.
Dr. Susan Van Cleve earned her BSN from the University of Pittsburgh, her MSN from Boston College, and her DNP from Robert Morris University. She works as PNP faculty at the University of Iowa and also as a Pediatric Mental Health Specialist in a private pediatric practice in Pittsburgh, where she provides comprehensive care for children and adolescents with developmental, behavioral, and mental health disorders.
- 1.75 Contact hours